Abstract: Several methods are described for generating mycelial scaffolds for use several technologies. In one embodiment, a mycelial scaffold is generated using a perfusion bioreactor system for cell-based meat technologies. In another embodiment, a mycelial scaffold is prepared for biomedical applications. The mycelial scaffolds may be generated from a liquid medium or from a solid substrate.

Abstract: A mycological biopolymer product consisting entirely of fungal mycelium is made by inoculating a nutritive substrate with a selected fungus in a sealed environment except for a void space, which space is subsequently filled with a network of undifferentiated fungal mycelium. The environmental conditions for producing the mycological biopolymer product, i.e. a high carbon dioxide (CO2) content (from 5% to 7% by volume) and an elevated temperature (from 85° F. to 95° F.), prevent full differentiation of the fungus into a mushroom. There are no stipe, cap, or spores produced. The biopolymer product grows into the void space of the tool, filling the space with an undifferentiated mycelium chitin-polymer, which is subsequently extracted from the substrate and dried.

Abstract: A mycological biopolymer product consisting entirely of fungal mycelium is made by inoculating a nutritive substrate with a selected fungus in a sealed environment except for a void space, which space is subsequently filled with a network of undifferentiated fungal mycelium. The environmental conditions for producing the mycological biopolymer product, i.e. a high carbon dioxide (CO2) content (from 5% to 7% by volume) and an elevated temperature (from 85° F. to 95° F.), prevent full differentiation of the fungus into a mushroom. There are no stipe, cap, or spores produced. The biopolymer product grows into the void space of the tool, filling the space with an undifferentiated mycelium chitin-polymer, which is subsequently extracted from the substrate and dried.

Abstract: Several methods are described for generating mycelial scaffolds for use several technologies. In one embodiment, a mycelial scaffold is generated using a perfusion bioreactor system for cell-based meat technologies. In another embodiment, a mycelial scaffold is prepared for biomedical applications. The mycelial scaffolds may be generated from a liquid medium or from a solid substrate.

Abstract: The composite biomaterial employs a binding organism (a filamentous fungi that produce mycelium) based on the material physical properties required for the composite biomaterial and a modulating organism (bacteria, fungus or yeast) based on a desired effect of the modulating organism on the binding organism. The modulating organism is selected based on the desired effect on the binding organism.

Abstract: The composite biomaterial employs a binding organism (a filamentous fungi that produce mycelium) based on the material physical properties required for the composite biomaterial and a modulating organism (bacteria, fungus or yeast) based on a desired effect of the modulating organism on the binding organism. The modulating organism is selected based on the desired effect on the binding organism.

Abstract: Several methods are described for generating mycelial scaffolds for use several technologies. In one embodiment, a mycelial scaffold is generated using a perfusion bioreactor system for cell-based meat technologies. In another embodiment, a mycelial scaffold is prepared for biomedical applications. The mycelial scaffolds may be generated from a liquid medium or from a solid substrate.

Abstract: The process aseptically inoculates a liquid media with a vegetative Xylaria fungal species to form a culture; statically incubates the culture in a vessel for a time sufficient to begin initiation of fruit body development and asexual sporulation and halts incubation at maximum conidia production prior to the beginning of sexual sporulation. Thereafter, the entire culture contents of the incubation vessel are macerated to homogenize the fungal biomass and conidia therein and form an inoculum.

Abstract: A self-supporting composite body comprising a substrate of discrete particles and a network of interconnected mycelia cells extending through and around the discrete particles and bonding the discrete particles together is characterized in being stiff and in having a density of greater than 18 pounds per cubic foot (pcf). The method of making the composite body includes compressing a mass of biocomposite material comprised of discrete particles and a network of interconnected mycelia cells in the presence of moisture into a compressed body having a density in excess of 18 pcf. Compression may take place batch wise in a press or continuously between a pair of movable endless conveyors.

Abstract: The method of making a composite biomaterial employs a binding organism (a filamentous fungi that produce mycelium) based on the material physical properties required for the composite biomaterial and a modulating organism (bacteria, fungus or yeast) based on a desired effect of the modulating organism on the binding organism. The modulating organism is selected based on the desired effect on the binding organism.

Abstract: In one embodiment, the process combines a fraction (up to 15%) of a lignocellulose substrate with supplemental nutritional material and hydrates the fraction to a moisture content of from 40% to 70% by weight. The hydrated substrate fraction is heat processed to remove ambient bioburden (yeast, mold, bacteria) and to maintain the hydrated substrate fraction in an aseptic condition. Thereafter, the hydrated substrate fraction is inoculated with a fungus and incubated to obtain a myceliated substrate which is then reduced into discrete particles. The remaining fraction of the substrate is combined with water and then combined with the discrete particles of myceliated substrate and incubated to obtain a second myceliated substrate which is then reduced into discrete particles. The second myceliated substrate is combined with supplemental nutritional material and incubated to obtain a third myceliated substrate composed of at least 10% mycelium.

Abstract: The process aseptically inoculates a liquid media with a vegetative Xylaria fungal species to form a culture; statically incubates the culture in a vessel for a time sufficient to begin initiation of fruit body development and asexual sporulation and halts incubation at maximum conidia production prior to the beginning of sexual sporulation. Thereafter, the entire culture contents of the incubation vessel are macerated to homogenize the fungal biomass and conidia therein and form an inoculum.

Abstract: In one embodiment, the process combines a fraction (up to 15%) of a lignocellulose substrate with supplemental nutritional material and hydrates the fraction to a moisture content of from 40% to 70% by weight. The hydrated substrate fraction is heat processed to remove ambient bioburden (yeast, mold, bacteria) and to maintain the hydrated substrate fraction in an aseptic condition. Thereafter, the hydrated substrate fraction is inoculated with a fungus and incubated to obtain a myceliated substrate which is then reduced into discrete particles. The remaining fraction of the substrate is combined with water and then combined with the discrete particles of myceliated substrate and incubated to obtain a second myceliated substrate which is then reduced into discrete particles. The second myceliated substrate is combined with supplemental nutritional material and incubated to obtain a third myceliated substrate composed of at least 10% mycelium.

Abstract: The method of making a composite biomaterial employs a binding organism (a filamentous fungi that produce mycelium) based on the material physical properties required for the composite biomaterial and a modulating organism (bacteria, fungus or yeast) based on a desired effect of the modulating organism on the binding organism. The modulating organism is selected based on the desired effect on the binding organism.

Abstract: A mycological biopolymer product consisting entirely of fungal mycelium is made by inoculating a nutritive substrate with a selected fungus in a sealed environment except for a void space, which space is subsequently filled with a network of undifferentiated fungal mycelium. The environmental conditions for producing the mycological biopolymer product, i.e. a high carbon dioxide (CO2) content (from 5% to 7% by volume) and an elevated temperature (from 85° F. to 95° F.), prevent full differentiation of the fungus into a mushroom. There are no stipe, cap, or spores produced. The biopolymer product grows into the void space of the tool, filling the space with an undifferentiated mycelium chitin-polymer, which is subsequently extracted from the substrate and dried.

Abstract: A self-supporting composite body comprising a substrate of discrete particles and a network of interconnected mycelia cells extending through and around the discrete particles and bonding the discrete particles together is characterized in being stiff and in having a density of greater than 18 pounds per cubic foot (pcf). The method of making the composite body includes compressing a mass of biocomposite material comprised of discrete particles and a network of interconnected mycelia cells in the presence of moisture into a compressed body having a density in excess of 18 pcf. Compression may take place batch wise. in a press or continuously between a pair of movable endless conveyors.

Abstract: A method of producing a fungal leachate solution comprises the steps of obtaining a feedstock of lignocellulosic substrate; colonizing the substrate with a selected fungus; and adding water to the colonized substrate to form a liquid medium containing at least one of sugar alcohol, a phenolic compound and a fatty acid. A leachate from the liquid medium can be used as a liquid culture medium to culture fungi.